Forecast Pharm Exec's 2012 Pipeline Report
There are a handful of drugs destined to reach blockbuster status in our 2012 Pipeline Report, but plenty of other half-billion-dollar drugs that, when strung together, make for a convincing portfolio, writes Ben Comer ...Read More
Health Reform The 'S' Word
In little more than two years, the main elements of the HCR will take hold across the nation. As implementation continues to ramp up, one of the more intriguing questions surrounding its activation is: Is the ‘S’ word being realized? That is, ‘savings’ ...Read More
Regulatory Taking Drugs Off the Short List
Drug shortages are increasing at an alarming rate. Between 2005 and 2010, the number of drug shortages per year leapt from 61 to 178. This year’s total, 220 as of October, already surpasses that of last year. Fortunately, FDA has taken a step that is intended to prevent drug shortages from becoming crises...Read More
Ad Stars 2012 Call for Entries
It’s that time again for the editors of Pharm Exec to narrow down its choices for our annual Ad Stars feature, recognizing the most clever, unique, and effective campaigns in pharma advertising over the past year. We’d like to extend an opportunity for you to submit an ad for consideration. Please feel free to share with us the campaign that your firm or agency feels truly helps the client stand apart from its competition ...For more information
// Board Appointment Wrapup: Chris A. Rallis and Anthony A. DiTonno to Oxygen Biotherapeutics (Morrisville, NC); David Gao to China Nuokang Bio-Pharmaceutical (Beijing); Michel Lagarde to Patheon (Toronto); and Sandford D. Smith to Aegerion Pharmaceuticals.
// BioNano Genomics (San Diego) hired Garth Monroe its new Chief Financial Officer. // Qforma (Santa Fe, NM) appointed Ian McGuinness to the position of Vice President, Business Development. // Former company founder Steve Gorlin, currently the Chairman and CEO of DemeRX, has been named Chairman of the Board of Directors at Dara Biosciences (Raleigh, N.C.). The company has also formally appointed David Drutz as CEO'.
You
are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe
To
ensure delivery to your Inbox, please add us to your
address book. If you need help doing this, click
here.
Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.
